Sabre Corporation
Sabre Corporation (SABR) Financial Performance & Income Statement Overview
Analyze Sabre Corporation (SABR) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Sabre Corporation (SABR) Income Statement & Financial Overview
View the income breakdown for Sabre Corporation SABR across both annual and quarterly reports.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $776.62M | $714.72M | $764.71M | $767.24M |
Cost of Revenue | $529.94M | $289.91M | $533.54M | $347.85M |
Gross Profit | $246.68M | $424.82M | $231.17M | $419.39M |
Gross Profit Ratio | $0.32 | $0.59 | $0.30 | $0.55 |
R&D Expenses | $0.00 | $213.16M | $0.00 | $219.27M |
SG&A Expenses | $143.28M | $154.57M | $161.05M | $156.96M |
Operating Expenses | $143.28M | $154.57M | $161.05M | $376.22M |
Total Costs & Expenses | $673.22M | $661.87M | $696.14M | $724.07M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $129.35M | $127.93M | $127.67M | $129.29M |
Depreciation & Amortization | $29.79M | $31.27M | $32.73M | $31.32M |
EBITDA | $137.63M | $68.78M | $106.30M | $97.99M |
EBITDA Ratio | $0.18 | $0.10 | $0.14 | $0.13 |
Operating Income | $103.40M | $57.09M | $70.13M | $43.17M |
Operating Income Ratio | $0.13 | $0.08 | $0.09 | $0.06 |
Other Income/Expenses (Net) | -$124.91M | -$148.43M | -$126.36M | -$125.57M |
Income Before Tax | -$21.51M | -$91.33M | -$56.23M | -$64.72M |
Income Before Tax Ratio | -$0.03 | -$0.13 | -$0.07 | -$0.08 |
Income Tax Expense | -$57.06M | -$16.38M | $6.90M | $4.77M |
Net Income | $35.34M | -$74.70M | -$62.82M | -$69.76M |
Net Income Ratio | $0.05 | -$0.10 | -$0.08 | -$0.09 |
EPS | $0.09 | -$0.19 | -$0.16 | -$0.18 |
Diluted EPS | $0.09 | -$0.19 | -$0.16 | -$0.18 |
Weighted Avg Shares Outstanding | $386.27M | $385.88M | $385.73M | $383.51M |
Weighted Avg Shares Outstanding (Diluted) | $455.26M | $385.88M | $385.73M | $383.51M |
Over the past four quarters, Sabre Corporation demonstrated steady revenue growth, increasing from $767.24M in Q2 2024 to $776.62M in Q1 2025. Operating income reached $103.40M in Q1 2025, maintaining a consistent 13% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $137.63M, reflecting operational efficiency. Net income rose to $35.34M, with EPS at $0.09. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan